NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Recent studies from University Medical Center add new data to breast cancer



October 30th, 2008

"Hypoxia is a hallmark of cancer. Hypoxia inducible factor-1 alpha (HIF-1 alpha) is the key regulator of the hypoxia response," scientists in Netherlands report.

"HIF-1 alpha is overexpressed during sporadic breast carcinogenesis and correlated with poor prognosis. Little is known on the role of HIF-1 alpha in hereditary breast carcinogenesis. A recent study suggests a role for BRCA1 in HIF-1 alpha regulation. We therefore examined the expression of HIF-1 alpha in BRCA1 related breast cancers. By immunohistochemistry we studied expression of HIF-1 alpha and some of its downstream targets in 30 hereditary invasive breast cancers in comparison with 200 sporadic controls....


Source: Women's Health Weekly (2008-10-30)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login